Highlights of US patent law in the life sciences in 2023

Highlights of US patent law in the life sciences in 2023

The US Supreme Court’s Amgen v Sanofi ruling is giving rise to more enablement challenges, while the Federal Circuit’s In re Cellect decision put a stamp on obviousness-type double patenting

Unlock unlimited access to all IAM content